Lis William

Director at ZLAB; Director at JSPR; Chief Executive Officer at PORTOLA PHARMACEUTICALS INC

Sold, on record
$28.6M
Dollars the filings state
Form 4 sales
26
Latest Aug 12, 2026
Form 144 notices
8
Proposed sales
Quarters with a sale
4 of the last 8
4 days with a sale in that time
Companies
3
Filed as an executive or holder

Companies

Sales by reason

4
Routine
4
Plan not stated
1
No plan
17
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Aug 12, 2026Routine

    ZLAB

    Sold 16.9% of their holdings

    $213k8,506 shares at $25.00

    Filed Aug 13, 2026Form 4

  2. Aug 12, 2026Notice

    ZLAB

    Filed a notice to sell 8,506 shares

    $213k8,506 shares

    Filed Aug 12, 2026Form 144

  3. Jun 22, 2026Routine

    ZLAB

    Sold 12.2% of their holdings

    $127k7,040 shares at $18.09

    Filed Jun 24, 2026Form 4

  4. Jun 22, 2026Notice

    ZLAB

    Filed a notice to sell 7,040 shares

    $127k7,040 shares

    Filed Jun 22, 2026Form 144

  5. Jun 20, 2025Unusual

    ZLAB

    Sold 28.2% of their holdings

    $493k13,814 shares at $35.67

    Filed Jun 23, 2025Form 4

  6. Jun 20, 2025Notice

    ZLAB

    Filed a notice to sell 13,814 shares

    $493k13,814 shares

    Filed Jun 20, 2025Form 144

  7. Feb 28, 2025Unusual

    ZLAB

    Sold 28.3% of their holdings

    $495k15,000 shares at $32.98

    Filed Mar 4, 2025Form 4

  8. Feb 28, 2025Notice

    ZLAB

    Filed a notice to sell 15,000 shares

    $495k15,000 shares

    Filed Feb 28, 2025Form 144

  9. Jul 1, 2024Routine

    ZLAB

    Sold 16.4% of their holdings

    $180k10,397 shares at $17.32

    Filed Jul 3, 2024Form 4

  10. Jul 1, 2024Notice

    ZLAB

    Filed a notice to sell 10,397 shares

    $179k10,397 shares

    Filed Jul 1, 2024Form 144

10 of 34

Every transaction

Every transaction on a Form 4 or Form 5 by Lis William
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Aug 12, 2026Aug 13, 2026ZLABDirectorSold8,506$25.00$213k41,931SEC
Jun 22, 2026Jun 24, 2026ZLABDirectorSold7,040$18.09$127k50,437SEC
Jun 17, 2026Jun 22, 2026ZLABDirectorAwarded22,37157,477SEC
Jun 20, 2025Jun 23, 2025ZLABDirectorSold13,814$35.67$493k35,106SEC
Jun 18, 2025Jun 23, 2025ZLABDirectorAwarded10,83148,920SEC
Feb 28, 2025Mar 4, 2025ZLABDirectorSold15,000$32.98$495k38,089SEC
Jul 1, 2024Jul 3, 2024ZLABDirectorSold10,397$17.32$180k53,089SEC
Jun 18, 2024Jun 20, 2024ZLABDirectorAwarded21,25363,486SEC
Oct 13, 2023Oct 13, 2023JSPRDirectorSold7,965$0.85$7k53,521SEC
Jun 29, 2023Jun 30, 2023ZLABDirectorAwarded18,903$26.45$500k42,233SEC
Jun 7, 2023Jun 8, 2023JSPRDirectorAwardedStock Option (right to buy)47,00047,000SEC
Apr 13, 2023Apr 14, 2023JSPRDirectorSold8,500$1.44$12k61,486SEC
Mar 3, 2023Mar 7, 2023ZLABDirectorSold5,434$38.31$208k23,330SEC
Oct 12, 2022Oct 13, 2022JSPRDirectorAwarded29,50069,986SEC
Jun 27, 2022Jun 28, 2022JSPRDirectorSold49,486$2.05$101k40,486SEC
Mar 21, 2022Mar 23, 2022JSPROfficer, DirectorAwardedStock Option (right to buy)197,472100,000SEC
Mar 21, 2022Mar 23, 2022JSPROfficer, DirectorAwarded89,97289,972SEC
Jan 20, 2022Jan 21, 2022ZLABDirectorSold1,926$53.40$103k34,114SEC
Jan 3, 2022Jan 4, 2022ZLABDirectorAwarded7,76336,040SEC
Jan 26, 2021Jan 28, 2021Eidos Therapeutics, Inc.DirectorReturned to the companyStock Option (Right to Buy)86,1120SEC
Jan 15, 2021Jan 20, 2021ZLABDirectorAwarded3,85228,277SEC
Jan 5, 2021Feb 14, 2022ZLABDirectorWithheld for tax5,350$129.14$691k22,927SEC
May 27, 2020May 29, 2020Eidos Therapeutics, Inc.DirectorAwardedStock Option (right to buy)21,52821,528SEC
Jun 12, 2019Jun 13, 2019Eidos Therapeutics, Inc.DirectorAwardedStock Option (right to buy)21,52821,528SEC
Dec 4, 2018Dec 7, 2018Eidos Therapeutics, Inc.DirectorAwardedStock Option (right to buy)43,05643,056SEC
Aug 23, 2018Aug 28, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax17,587$26.05$458k204,448SEC
Jul 28, 2018Aug 28, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerExercised options35,000222,035SEC
Jun 6, 2018Jun 8, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerSold5,113$45.21$231k222,035SEC
May 22, 2018May 24, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax6,491$40.82$265k227,148SEC
May 22, 2018May 24, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwarded12,890233,639SEC
Mar 2, 2018Mar 6, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax19,184$32.53$624k70,624SEC
Jan 31, 2018Feb 2, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwardedStock Option (Right to Buy)100,000100,000SEC
Jan 31, 2018Feb 2, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwarded25,00025,000SEC
Aug 16, 2017Aug 18, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax7,435$54.86$408k0SEC
Jun 28, 2017Jun 29, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerSold269,299$55.43$14.9M0SEC
Jun 28, 2017Jun 29, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerExercised or settledStock Option (Right to Buy)269,299101,820SEC
Jun 28, 2017Jun 29, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerExercised options269,299$8.33$2.2M14,150SEC
Apr 11, 2017Apr 11, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerSold6,750$36.06$243k4,730SEC
Mar 2, 2017Mar 3, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax13,669$38.61$528k112,839SEC
Jan 30, 2017Feb 1, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwardedStock Option (Right to Buy)171,87534,375SEC
Jan 30, 2017Feb 1, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwarded34,37534,375SEC
May 2, 2016May 3, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerSold5,675$23.86$135k18,333SEC
May 1, 2016May 3, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwardedStock Option80,00080,000SEC
May 1, 2016May 3, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwarded40,00040,000SEC
Mar 2, 2016Mar 4, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerWithheld for tax3,492$31.75$111k24,008SEC
Jan 27, 2016Jan 29, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwardedStock Option (Right to Buy)140,62528,125SEC
Jan 27, 2016Jan 29, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerAwarded28,12528,125SEC
Jul 15, 2015Jul 15, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerSold50,000$50.00$2.5M0SEC
Jul 15, 2015Jul 15, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerExercised or settledStock Option (Right to Buy)50,00057,070SEC
Jul 15, 2015Jul 15, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerExercised options50,000$8.50$425k50,000SEC
Page 1

Sales and notices (34)

Form 144 notices and Form 4 sales by Lis William
Source
Aug 12, 2026Aug 13, 2026ZLABDirectorForm 4 sale8,506$213k16.9%RoutineSEC
Aug 12, 2026Aug 12, 2026ZLABDirectorForm 144 notice8,506$213kNoticeSEC
Jun 22, 2026Jun 24, 2026ZLABDirectorForm 4 sale7,040$127k12.2%RoutineSEC
Jun 22, 2026Jun 22, 2026ZLABDirectorForm 144 notice7,040$127kNoticeSEC
Jun 20, 2025Jun 23, 2025ZLABDirectorForm 4 sale13,814$493k28.2%UnusualSEC
Jun 20, 2025Jun 20, 2025ZLABDirectorForm 144 notice13,814$493kNoticeSEC
Feb 28, 2025Mar 4, 2025ZLABDirectorForm 4 sale15,000$495k28.3%UnusualSEC
Feb 28, 2025Feb 28, 2025ZLABDirectorForm 144 notice15,000$495kNoticeSEC
Jul 1, 2024Jul 3, 2024ZLABDirectorForm 4 sale10,397$180k16.4%RoutineSEC
Jul 1, 2024Jul 1, 2024ZLABDirectorForm 144 notice10,397$179kNoticeSEC
Mar 6, 2024Mar 6, 2024JSPRDirectorForm 144 notice16,000$336kNoticeSEC
Oct 13, 2023Oct 13, 2023JSPRDirectorForm 144 notice7,965$7kNoticeSEC
Oct 13, 2023Oct 13, 2023JSPRDirectorForm 4 sale7,965$7k13.0%RoutineSEC
Apr 13, 2023Apr 14, 2023JSPRDirectorForm 4 sale8,500$12k12.1%No planSEC
Apr 13, 2023Apr 13, 2023JSPRDirectorForm 144 notice8,500$12kNoticeSEC
Mar 3, 2023Mar 7, 2023ZLABDirectorForm 4 sale5,434$208k18.9%Plan not statedSEC
Jun 27, 2022Jun 28, 2022JSPRDirectorForm 4 sale49,486$101k55.0%UnusualSEC
Jan 20, 2022Jan 21, 2022ZLABDirectorForm 4 sale1,926$103k5.3%Plan not statedSEC
Jun 6, 2018Jun 8, 2018PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale5,113$231k2.3%Plan not statedSEC
Jun 28, 2017Jun 29, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale269,299$14.9M100.0%UnusualSEC
Apr 11, 2017Apr 11, 2017PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale6,750$243k58.8%UnusualSEC
May 2, 2016May 3, 2016PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale5,675$135k23.6%Plan not statedSEC
Jul 15, 2015Jul 15, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale50,000$2.5M100.0%UnusualSEC
Jul 2, 2015Jul 2, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale15,000$684k100.0%UnusualSEC
Jul 1, 2015Jul 1, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale30,000$1.4M100.0%UnusualSEC
Apr 30, 2015May 1, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale45,000$1.6M100.0%UnusualSEC
Jan 20, 2015Jan 20, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale20,000$546k100.0%UnusualSEC
Jan 16, 2015Jan 16, 2015PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale20,000$539k100.0%UnusualSEC
Nov 20, 2014Nov 20, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale40,000$1.1M100.0%UnusualSEC
Nov 17, 2014Nov 17, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale30,000$801k100.0%UnusualSEC
Jul 3, 2014Jul 3, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale30,000$912k100.0%UnusualSEC
Jun 30, 2014Jul 1, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale10,000$292k100.0%UnusualSEC
May 27, 2014May 27, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale30,000$625k100.0%UnusualSEC
May 21, 2014May 21, 2014PORTOLA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale10,000$199k100.0%UnusualSEC